![](http://kobiolabs.com/wp-content/uploads/2020/10/rd-icon.png)
R&D
The core of the bio-industry to select the next 10 technologies
R&D
Pipeline
Target Therapeutic Area
![](http://kobiolabs.com/wp-content/uploads/2020/11/rd_03_pipeline_01_01.png)
Immunity
Psoriasis
IBD
Asthma
Atopic Dermatitis
Immuno-oncology
![](http://kobiolabs.com/wp-content/uploads/2020/11/rd_03_pipeline_icon_02-2.png)
Metabolism
Diabetes/Obesity
NASH
![](http://kobiolabs.com/wp-content/uploads/2020/11/rd_03_pipeline_icon_03-2.png)
Brain
Autism Spectrum Disorder
![](http://kobiolabs.com/wp-content/uploads/2020/11/rd_03_pipeline_01_01.png)
Immunity
Psoriasis
IBD
Asthma
Atopic Dermatitis
Immuno-oncology
![](http://kobiolabs.com/wp-content/uploads/2020/11/rd_03_pipeline_01_02.png)
Metabolism
Diabetes/Obesity
NASH
![](http://kobiolabs.com/wp-content/uploads/2020/11/rd_03_pipeline_01_03.png)
Brain
Autism Spectrum Disorder
Microbiome New Drug Development Pipeline
New Drug Development Focusing on Immune/Metabolic/Neurological
![](http://kobiolabs.com/wp-content/uploads/2023/08/rd_03_pipeline_02_eng_edit-1.jpg)